Management of Acute Ischemic Stroke with Lower GI Bleeding

Initial Assessment and Resuscitation

For patients with acute ischemic stroke complicated by lower gastrointestinal bleeding, immediate resuscitation should occur concurrently with the initial evaluation, including fluid resuscitation and blood transfusion if necessary for hemodynamic instability, as recommended by the American Gastroenterological Association 1
The severity of GI bleeding should be assessed through clinical parameters, such as hemoglobin levels, vital signs, and presence of active bleeding, with a strength of evidence level of high, according to the American Gastroenterological Association 1, 3
Patients should be stratified based on bleeding severity into one of four categories: minor bleeding that resolves with conservative therapy, chronic intermittent bleeding, severe life-threatening bleeding with periods of stability, or continual active bleeding, as classified by the American Gastroenterological Association 1, 4

For patients with active lower GI bleeding, urgent diagnostic evaluation is required, with colonoscopy as the first-line diagnostic tool for most patients, as recommended by the American Gastroenterological Association 1, 4
For severe, ongoing bleeding with hemodynamic instability, angiography may be more appropriate, with a strength of evidence level of moderate, according to the American Gastroenterological Association 1
Coagulopathy or thrombocytopenia should be corrected with fresh frozen plasma or platelets, respectively, as recommended by the American Gastroenterological Association 1
For patients with GI malignancy or recent GI bleeding, IV thrombolysis is contraindicated due to increased bleeding risk, as stated by the American Heart Association 2

For non-thrombolyzed patients with acute ischemic stroke, early antiplatelet therapy is generally recommended, but must be temporarily withheld in the setting of active GI bleeding, as recommended by the American College of Chest Physicians 5, 6
Once bleeding is controlled, dual antiplatelet therapy with clopidogrel and ASA should be initiated for 21-30 days, followed by monotherapy, for very high-risk TIA or minor ischemic stroke, as recommended by the American Heart Association 6, 7
For patients at higher risk of GI bleeding on dual antiplatelet therapy, GI protection should be considered, with a strength of evidence level of high, according to the American Heart Association 6, 7

Enteral diet should be started within 7 days of admission after acute stroke, as recommended by the American Heart Association 8
For patients with dysphagia, nasogastric tubes can be used initially, with percutaneous gastrostomy tubes considered for those with anticipated persistent swallowing difficulties, as recommended by the American Heart Association 8
Nutritional supplements should be considered for malnourished patients or those at risk of malnourishment, with a strength of evidence level of moderate, according to the American Heart Association 8

Once bleeding is controlled, antiplatelet therapy should be resumed as it is critical for secondary stroke prevention, as recommended by the American Heart Association 6, 7
For patients who received thrombolysis, antiplatelet agents should be delayed until after the 24-hour post-thrombolysis scan has excluded intracranial hemorrhage, as recommended by the American Heart Association 7
In patients unable to take oral medications, ASA and clopidogrel may be given by enteral tube or ASA by rectal suppository, as recommended by the American Heart Association 7